奥马利祖马布用于对抗癌药物过敏反应的治疗
Piyush Grover1,2,3, Matthew Krummenacher1, Timothy Loy1
1Department of Immunology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
奥马利祖马布有效地预防对抗癌药物的过敏反应,使患者能够继续治疗. 这种方法避免了重复的标准脱敏,没有观察到安全问题.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对抗癌药物的过敏反应是治疗中断的常见原因.
- 标准的药物脱敏剂只能提供暂时的耐受性,需要重复的程序.
研究的目的:
- 评估奥马利祖马布在预防抗癌药物立即和延迟过敏反应方面的疗效.
- 评估奥马利祖马布能否使患者能够在没有标准脱敏的情况下恢复他们预期的化疗方案.
主要方法:
- 一项涉及对抗癌药物过敏反应的患者的研究.
- 服用抗免疫球蛋白E抗体奥马利祖马布,以缓解过敏症.
- 监测患者的反应和继续抗癌药物治疗的能力.
主要成果:
- 在8名患者中,有7名患者成功恢复了他们处方的抗癌药物治疗方案.
- 奥马利祖马布有效地克服了即时和延迟的过敏反应.
- 没有任何不良安全事件与使用奥马利祖马布有关.
结论:
- 奥马利祖马布是对抗癌药物过敏反应的有前途的治疗选择.
- 这种方法提供了一种潜在的更可持续的替代方案,而不是重复的标准脱敏方案.
- 需要进一步的研究来证实这些发现在更大的患者队列中.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:57Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Tumor Immunotherapy
